$SNDK

Jim Cramer's top 10 things to watch in the stock market Thursday

Jim Cramer’s market watch highlights mixed stock futures, with Nasdaq pressured by post-earnings weakness at Sandisk and Western Digital. He notes price-target hikes for Eli Lilly, Shopify, Block, Duolingo, Expedia, and CVS Health, plus a guidance cut for Honeywell Aerospace after its June spin-off. SpaceX shares begin trading after IPO lock-up expiration.

Original reporting
Published Aug 6, 2026, 1:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 1:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Jim Cramer's top 10 things to watch in the stock market Thursday — source image
Decision brief

The 30-second read

$SNDKBearishLow
01

Why it matters

The only clearly time-sensitive negative catalysts in the text are Honeywell Aerospace’s steep guidance cut and the storage names’ margin/revenue guide disappointments. Other items are primarily analyst target changes and narrative framing after already-reported quarters.

02

Market read

Traders should focus on near-term repricing risk from guidance quality (HON, SNDK, WDC, DUOL) while treating PT hikes (LLY, SHOP, EXPE, CVS) as sentiment support rather than fresh fundamentals.

03

What to watch

Lock-up expiration mechanics (SpaceX) and supply-chain-driven guidance cuts (Honeywell Aerospace) can dominate near-term price action more than the longer-term thesis discussed.

Relevance 4/10Novelty 3/10Timing: pre-market today, Aug. 6 watchlist catalysts

Background

This is a multi-stock “things to watch” market column summarizing pre-market moves and post-earnings outlook reactions across several sectors.

Company-level read

Ticker impact

$SNDKBearishMedium confidence
Context

Cramer flags Sandisk’s September-quarter gross margin guide as disappointing, despite durable AI-driven demand commentary.

Expected impact

Choppy to downside-biased trading until investors focus on margin trajectory and any follow-on revisions.

Evidence & confidence

The article cites a specific guidance disappointment (gross margin guide) as the key incremental negative catalyst for the stock’s tape.

$WDCBearishMedium confidence
Context

Western Digital’s revenue growth and margin expansion forecast trailed Seagate, per the article’s post-earnings outlook recap.

Expected impact

Potential continued underperformance versus peers until guidance catches up or new demand/margin evidence emerges.

Evidence & confidence

The text highlights a concrete forecast shortfall versus Seagate, which is a direct read-through for WDC’s near-term earnings power.

$LLYBullishMedium confidence
Context

Cramer notes multiple analyst price target hikes for Eli Lilly after another beat-and-raise quarter, highlighting retatrutide interest.

Expected impact

Supportive bias for the stock, though the article is more about analyst actions than new company disclosures.

Evidence & confidence

The incremental item in the text is the cluster of PT hikes tied to the prior beat-and-raise, which can move sentiment but is not a fresh earnings print in this article.

$HONBearishHigh confidence
Context

Honeywell Aerospace’s first earnings report since its June spin-off is described as shockingly bad, with a steep full-year guidance cut.

Expected impact

Further downside risk and elevated volatility until credibility with the Street improves.

Evidence & confidence

The article cites a specific, time-relevant event: a steep guidance cut tied to supply chain issues, with shares down over 15% premarket.

$SHOPBullishMedium confidence
Context

Cramer highlights bullish analyst target hikes for Shopify after a better-than-expected quarter and upbeat guidance, citing ChatGPT and Gemini discovery engines.

Expected impact

Likely continued upside bias while investors price in durable guidance and AI-driven engagement benefits.

Evidence & confidence

The article provides a concrete catalyst (better-than-expected quarter and upbeat guidance) plus multiple PT hikes, though it is still a watchlist-style recap.

$DUOLNeutralMedium confidence
Context

Duolingo is flagged for a UBS price target hike after earnings, but the third-quarter revenue guide missed estimates and the stock is down over 6%.

Expected impact

Range-bound to volatile trading as the market weighs profitability progress against the missed revenue guide.

Evidence & confidence

The article explicitly pairs the PT hike with a specific guide miss, which is the key near-term driver for DUOL.

$EXPEBullishMedium confidence
Context

Expedia sees multiple price target bumps after a solid second-quarter beat and a full-year guidance raise, per the article.

Expected impact

Upside bias if investors continue to buy the raised full-year outlook.

Evidence & confidence

The text cites concrete analyst actions tied to beat-and-raise fundamentals, but does not add new company-specific numbers beyond the recap.

$CVSNeutralMedium confidence
Context

UBS and Barclays raised price targets on CVS Health despite the stock falling 5% yesterday on earnings, with concerns about Caremark membership declines.

Expected impact

Choppy trading until membership trend clarity offsets the earnings disappointment.

Evidence & confidence

The article’s incremental driver is the juxtaposition of PT hikes against a specific concern (Caremark membership declines) mentioned as the reason for the prior drop.

Market effects

AI-adjacent storage and software names (SNDK, WDC, SHOP, DUOL) are being traded on post-earnings outlook quality, especially margins and revenue guides.

US-focused equity sentiment, with Nasdaq weakness tied to storage post-earnings slides.

Oil and geopolitics backdrop (Strait of Hormuz traffic deal talk) is cited as mildly supportive for WTI, indirectly affecting risk appetite.

Counterpoint

Analyst price target hikes and “durable demand” narratives may be insufficient if margin and revenue guides are still deteriorating, so stocks could fade despite upgrades.

Key entities

  • Sandisk

    Guidance disappointment cited via gross margin guide for the September quarter.

  • Western Digital

    Forecast for revenue growth and margin expansion described as trailing Seagate.

  • SpaceX

    Lock-up expiration described as enabling nearly a billion new shares to trade today.

  • Eli Lilly

    Analyst price target hikes after a beat-and-raise quarter, with retatrutide highlighted.

  • Honeywell Aerospace

    First earnings since June spin-off described as shockingly bad with steep full-year guidance cut.

Related articles

$CVSMed

Healthcare giant slashes key consultation fee to beat rivals

CVS Health cut the cash price of MinuteClinic online weight-loss consultations to $29 from Aug. 5, with no membership or monthly fee, and said the visit is the entry point for GLP-1 evaluations. The company also reported adjusted EPS of $2.58 on revenue of $106.1B and raised full-year guidance to $7.90-$8.10. CVS shares fell after a Caremark membership decline warning.

$MUMed

Micron Stock Falls After Citi Slashes Price Target on Memory Risks

Micron (MU) and SanDisk (SNDK) fell Friday as investors reduced exposure to memory chips after Citi cautioned on DRAM and NAND pricing. Citi analyst Atif Malik kept a Buy on Micron but cut his price target to $1,150 from $1,400, citing moderating prices and longer-term risks from expanding Chinese production. Other chipmakers also declined.